Literature DB >> 1182734

Effects of verapamil on infarct size following experimental coronary occlusion.

H J Smith, B N Singh, H D Nisbet, R M Norris.   

Abstract

Open-chest anaesthetized dogs were given verapamil after left anterior descending artery occlusion, and ST-segment alterations and haemodynamic variables were monitored. Verapamil produced a highly significant reduction in ST-segment elevation in the epicardial electrocardiogram and prevented the haemodynamic deterioration seen in the control animals in which ST-segment elevation persisted. The apparent protective effect of verapamil in myocardial ischaemia is discussed in relation to its ability to inhibit selectively the transmembrane fluxes of calcium ions in excitable tissues.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1182734     DOI: 10.1093/cvr/9.4.569

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  15 in total

1.  The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

2.  Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial.

Authors:  L Thuesen; J R Jørgensen; H J Kvistgaard; J A Sørensen; M Vaeth; E B Jensen; J J Jensen; L Hagerup
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-02

Review 3.  Role of calcium antagonists in cardiovascular therapy.

Authors:  H Dargie; E Rowland; D Krikler
Journal:  Br Heart J       Date:  1981-07

4.  The antidysrhythmic aminosteroid, ORG 6001, reduces the ST-segment elevation produced by coronary occlusion in the dog.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

5.  Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administration.

Authors:  R Ferrari; G M Boffa; C Ceconi; S Curello; A Boraso; S Ghielmi; A Cargnoni
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

6.  Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.

Authors:  H Dong; J Z Sheng; C M Lee; T M Wong
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

7.  Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction.

Authors:  W Bernauer
Journal:  Klin Wochenschr       Date:  1982-01-15

8.  The Danish studies on verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 9.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

10.  The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats.

Authors:  O Fagbemi; K A Kane; F M McDonald; J R Parratt; A L Rothaul
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.